Retham Technologies, Inc.

Wauwatosa, WI

UEI
KDM9HGS7NFT9
CAGE
7VR31
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1225 Discovery Pkwy #260a, Wauwatosa, WI 53226, USA
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Similar vendors

SBA capabilities narrative

Develop In vitro diagnostics

Quick answers

Is Retham Technologies, Inc. registered in SAM.gov?

Yes. Retham Technologies, Inc.'s SAM.gov registration is active through July 27, 2027.

What is Retham Technologies, Inc.'s most recent federal award?

Retham Technologies, Inc.'s most recent federal grant award is An in vitro diagnostic assay for the early and accurate detection of platelet-activating antibodies associated with… (R44HL147734), from National Heart Lung and Blood Institute (NIH), on June 15, 2019.

On GovTribe

See Retham Technologies, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors